Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

NCT02632045 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Breast Carcinoma

Interventions

DRUG: LEE-011
DRUG: Fulvestrant
DRUG: Placebo

Sponsor

Melissa K Accordino

Collaborators

[object Object]